Eftychia Eirini Psarelli

3.1k total citations
24 papers, 538 citations indexed

About

Eftychia Eirini Psarelli is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Eftychia Eirini Psarelli has authored 24 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Eftychia Eirini Psarelli's work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (6 papers) and Metabolism and Genetic Disorders (5 papers). Eftychia Eirini Psarelli is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (6 papers) and Metabolism and Genetic Disorders (5 papers). Eftychia Eirini Psarelli collaborates with scholars based in United Kingdom, Germany and Sweden. Eftychia Eirini Psarelli's co-authors include Paula Ghaneh, John P. Neoptolemos, Christopher Halloran, Trevor F. Cox, Daniel H. Palmer, Harpreet Wasan, Markus W. Büchler, Jonathan Wadsley, L. Ranganath and Michael P. W. Grocott and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British journal of surgery.

In The Last Decade

Eftychia Eirini Psarelli

24 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eftychia Eirini Psarelli United Kingdom 13 321 196 138 124 92 24 538
Hanneke Wilmink Netherlands 13 127 0.4× 168 0.9× 133 1.0× 68 0.5× 57 0.6× 28 541
H. U. Kloer Germany 6 130 0.4× 428 2.2× 43 0.3× 89 0.7× 165 1.8× 13 691
Ulf Lundstam Sweden 10 87 0.3× 167 0.9× 34 0.2× 100 0.8× 68 0.7× 15 465
Yusuke Kumamoto Japan 15 166 0.5× 287 1.5× 93 0.7× 54 0.4× 179 1.9× 55 578
Markus Wortmann Germany 16 42 0.1× 172 0.9× 320 2.3× 91 0.7× 264 2.9× 32 634
Hana Kalábová Czechia 13 215 0.7× 38 0.2× 112 0.8× 117 0.9× 91 1.0× 42 421
C Villabona Spain 10 121 0.4× 158 0.8× 50 0.4× 28 0.2× 48 0.5× 24 503
Jiri Frohlich Canada 7 215 0.7× 391 2.0× 17 0.1× 82 0.7× 157 1.7× 13 596
Shigeyuki Nagata Japan 16 118 0.4× 200 1.0× 137 1.0× 32 0.3× 53 0.6× 59 627
Seikan Hai Japan 18 253 0.8× 492 2.5× 215 1.6× 55 0.4× 115 1.3× 63 959

Countries citing papers authored by Eftychia Eirini Psarelli

Since Specialization
Citations

This map shows the geographic impact of Eftychia Eirini Psarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eftychia Eirini Psarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eftychia Eirini Psarelli more than expected).

Fields of papers citing papers by Eftychia Eirini Psarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eftychia Eirini Psarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eftychia Eirini Psarelli. The network helps show where Eftychia Eirini Psarelli may publish in the future.

Co-authorship network of co-authors of Eftychia Eirini Psarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Eftychia Eirini Psarelli. A scholar is included among the top collaborators of Eftychia Eirini Psarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eftychia Eirini Psarelli. Eftychia Eirini Psarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oldfield, Lucy, A.G. Evans, Claire Jenkinson, et al.. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBioMedicine. 75. 103802–103802. 23 indexed citations
2.
3.
Psarelli, Eftychia Eirini, Sobhan Vinjamuri, Bal Sanghera, et al.. (2020). Prognostic value of 18FDG PET/CT volumetric parameters in the survival prediction of patients with pancreatic cancer. European Journal of Surgical Oncology. 46(8). 1532–1538. 12 indexed citations
4.
Khedr, Milad, Anna M. Milan, Andrew Davison, et al.. (2020). The nutritional status of people with alkaptonuria: An exploratory analysis suggests a protein/energy dilemma. JIMD Reports. 53(1). 45–60. 15 indexed citations
5.
6.
7.
Oldfield, Lucy, Robert N. Hanson, William Greenhalf, et al.. (2020). UK Early Detection Initiative (UK-EDI) for Pancreatic Cancer. Pancreatology. 20. S120–S121. 3 indexed citations
8.
Bird, N., Mohamed Elmasry, Robert Jones, et al.. (2017). Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy. British journal of surgery. 104(4). 328–336. 35 indexed citations
9.
Neoptolemos, John P., Paula Ghaneh, David Cunningham, et al.. (2016). ESPAC-4 : A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma. Pancreas. 45(10). 1529–1529. 2 indexed citations
10.
11.
12.
Subramanian, Sreedhar, Eftychia Eirini Psarelli, Paul Collins, et al.. (2015). Colonoscopy performance is stable during the course of an extended three-session working day. SHILAP Revista de lepidopterología. 3(5). E494–E500. 10 indexed citations
13.
Sutherland, Hazel, Peter J. Wilson, Eftychia Eirini Psarelli, et al.. (2015). Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice. JIMD Reports. 24. 45–50. 37 indexed citations
14.
Sultana, Asma, Richard Jackson, Timothy Gilbert, et al.. (2015). What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses. Clinical and Translational Gastroenterology. 6(12). e130–e130. 37 indexed citations
15.
Geraghty, Joe, et al.. (2015). The 5‐year outcome of patients having incomplete colonoscopy. Colorectal Disease. 17(4). 298–303. 7 indexed citations
16.
Olsson, Birgitta, Trevor F. Cox, Eftychia Eirini Psarelli, et al.. (2015). Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with Alkaptonuria. JIMD Reports. 24. 21–27. 27 indexed citations
17.
Moots, Robert J., et al.. (2014). Impact of Obesity on 1 Year Outcomes: Results from the Meteor Foundation International Rheumatoid Arthritis Cohort. Data Archiving and Networked Services (DANS). 2 indexed citations
18.
Alabraba, Edward, et al.. (2014). The role of ultrasound in the management of patients with occult groin hernias. International Journal of Surgery. 12(9). 918–922. 15 indexed citations
19.
Dunne, Declan F.J., Vincent Yip, Robert Jones, et al.. (2014). Enhanced recovery in the resection of colorectal liver metastases. Journal of Surgical Oncology. 110(2). 197–202. 41 indexed citations
20.
Psarelli, Eftychia Eirini, Trevor F. Cox, & L. Ranganath. (2013). Clinical development of nitisinone for alkaptonuria (developakure) - a rare disease clinical trials design. Trials. 14(S1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanneke Wilmink Breakdown of academic impact, for papers by H. U. Kloer Breakdown of academic impact, for papers by Ulf Lundstam Breakdown of academic impact, for papers by Yusuke Kumamoto Breakdown of academic impact, for papers by Markus Wortmann Breakdown of academic impact, for papers by Hana Kalábová Breakdown of academic impact, for papers by C Villabona Breakdown of academic impact, for papers by Jiri Frohlich Breakdown of academic impact, for papers by Shigeyuki Nagata Breakdown of academic impact, for papers by Seikan Hai
Rankless by CCL
2026